195 related articles for article (PubMed ID: 24124614)
1. Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherin.
Manuel Iglesias J; Beloqui I; Garcia-Garcia F; Leis O; Vazquez-Martin A; Eguiara A; Cufi S; Pavon A; Menendez JA; Dopazo J; Martin AG
PLoS One; 2013; 8(10):e77281. PubMed ID: 24124614
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC).
Graham ÉA; Mallet JF; Jambi M; Nishioka H; Homma K; Matar C
Cancer Biol Ther; 2017 Oct; 18(10):765-774. PubMed ID: 28886271
[TBL] [Abstract][Full Text] [Related]
3. Monocytes and macrophages, implications for breast cancer migration and stem cell-like activity and treatment.
Ward R; Sims AH; Lee A; Lo C; Wynne L; Yusuf H; Gregson H; Lisanti MP; Sotgia F; Landberg G; Lamb R
Oncotarget; 2015 Jun; 6(16):14687-99. PubMed ID: 26008983
[TBL] [Abstract][Full Text] [Related]
4. Comparative EPR Studies on the Influence of Genistein on Free Radicals in Non-Irradiated and UV-Irradiated MCF7, T47D and MDA-MB-231 Breast Cancer Cells.
Jurzak M; Ramos P; Pilawa B; Bednarek IA
Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540131
[TBL] [Abstract][Full Text] [Related]
5. AI identifies potent inducers of breast cancer stem cell differentiation based on adversarial learning from gene expression data.
Li Z; Napolitano A; Fedele M; Gao X; Napolitano F
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38701411
[TBL] [Abstract][Full Text] [Related]
6. Mammosphere formation assay from human breast cancer tissues and cell lines.
Lombardo Y; de Giorgio A; Coombes CR; Stebbing J; Castellano L
J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867607
[TBL] [Abstract][Full Text] [Related]
7. The Story of MCF-7 Breast Cancer Cell Line: 40 years of Experience in Research.
Comşa Ş; Cîmpean AM; Raica M
Anticancer Res; 2015 Jun; 35(6):3147-54. PubMed ID: 26026074
[TBL] [Abstract][Full Text] [Related]
8. Stem cells. Asymmetric apportioning of aged mitochondria between daughter cells is required for stemness.
Katajisto P; Döhla J; Chaffer CL; Pentinmikko N; Marjanovic N; Iqbal S; Zoncu R; Chen W; Weinberg RA; Sabatini DM
Science; 2015 Apr; 348(6232):340-3. PubMed ID: 25837514
[TBL] [Abstract][Full Text] [Related]
9. Comparison of mammosphere formation from breast cancer cell lines and primary breast tumors.
Wang R; Lv Q; Meng W; Tan Q; Zhang S; Mo X; Yang X
J Thorac Dis; 2014 Jun; 6(6):829-37. PubMed ID: 24977009
[TBL] [Abstract][Full Text] [Related]
10. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.
Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S
Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of inactivation of E-cadherin in breast cancer cell lines.
Hiraguri S; Godfrey T; Nakamura H; Graff J; Collins C; Shayesteh L; Doggett N; Johnson K; Wheelock M; Herman J; Baylin S; Pinkel D; Gray J
Cancer Res; 1998 May; 58(9):1972-7. PubMed ID: 9581841
[TBL] [Abstract][Full Text] [Related]
12. Regulation of breast cancer stem cell features.
Czerwinska P; Kaminska B
Contemp Oncol (Pozn); 2015; 19(1A):A7-A15. PubMed ID: 25691826
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition.
Lamb R; Harrison H; Hulit J; Smith DL; Lisanti MP; Sotgia F
Oncotarget; 2014 Nov; 5(22):11029-37. PubMed ID: 25415228
[TBL] [Abstract][Full Text] [Related]
14. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
[TBL] [Abstract][Full Text] [Related]
15. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease.
Lamb R; Ozsvari B; Lisanti CL; Tanowitz HB; Howell A; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2015 Mar; 6(7):4569-84. PubMed ID: 25625193
[TBL] [Abstract][Full Text] [Related]
16. Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells.
Lawson DA; Bhakta NR; Kessenbrock K; Prummel KD; Yu Y; Takai K; Zhou A; Eyob H; Balakrishnan S; Wang CY; Yaswen P; Goga A; Werb Z
Nature; 2015 Oct; 526(7571):131-5. PubMed ID: 26416748
[TBL] [Abstract][Full Text] [Related]
17. Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization.
Sabatier R; Finetti P; Guille A; Adelaide J; Chaffanet M; Viens P; Birnbaum D; Bertucci F
Mol Cancer; 2014 Oct; 13():228. PubMed ID: 25277734
[TBL] [Abstract][Full Text] [Related]
18. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.
Matano M; Date S; Shimokawa M; Takano A; Fujii M; Ohta Y; Watanabe T; Kanai T; Sato T
Nat Med; 2015 Mar; 21(3):256-62. PubMed ID: 25706875
[TBL] [Abstract][Full Text] [Related]
19. A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype.
Wolf J; Dewi DL; Fredebohm J; Müller-Decker K; Flechtenmacher C; Hoheisel JD; Boettcher M
Breast Cancer Res; 2013 Nov; 15(6):R109. PubMed ID: 24229464
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer.
Thakur R; Trivedi R; Rastogi N; Singh M; Mishra DP
Sci Rep; 2015 May; 5():10194. PubMed ID: 25973915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
